These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26665263)

  • 21. Clobetasol propionate lotion in the treatment of moderate to severe plaque-type psoriasis.
    Decroix J; Pres H; Tsankov N; Poncet M; Arsonnaud S
    Cutis; 2004 Sep; 74(3):201-6. PubMed ID: 15499763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Newer treatment options for patients with moderate-to-severe psoriatic disease.
    Roebuck HL
    Nurse Pract; 2006 Aug; 31(8):5-6,11. PubMed ID: 16966969
    [No Abstract]   [Full Text] [Related]  

  • 23. Clobetasol propionate foam 0.05% as a novel topical formulation for plaque-type and scalp psoriasis.
    Mazzotta A; Esposito M; Carboni I; Schipani C; Chimenti S
    J Dermatolog Treat; 2007; 18(2):84-7. PubMed ID: 17520464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lichen sclerosus et atrophicus of the oral cavity: report of two cases.
    Brown AR; Dunlap CL; Bussard DA; Lask JT
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Aug; 84(2):165-70. PubMed ID: 9269018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral mucosa and cutaneous manifestations of psoriasis in an older patient: A case report.
    Bertolini GR; Teixeira LR; Chahud F; Elias D; da Silva Souza C; Lourenço AG; Motta ACF
    Gerodontology; 2023 Dec; 40(4):518-522. PubMed ID: 37971285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis.
    Lebwohl M; Sherer D; Washenik K; Krueger GG; Menter A; Koo J; Feldman SR
    Int J Dermatol; 2002 May; 41(5):269-74. PubMed ID: 12100701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An intra-individual randomized safety and efficacy comparison of clobetasol propionate 0.05% spray and its vehicle in the treatment of plaque psoriasis.
    Beutner K; Chakrabarty A; Lemke S; Yu K
    J Drugs Dermatol; 2006 Apr; 5(4):357-60. PubMed ID: 16673804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leprosy and psoriasis co-existence.
    Thawani R; Goel A
    Indian J Med Sci; 2012; 66(9-10):241-4. PubMed ID: 23897572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral psoriasis.
    Salmon TN; Robertson GR; Tracy NH; Hiatt WR
    Oral Surg Oral Med Oral Pathol; 1974 Jul; 38(1):48-54. PubMed ID: 4525672
    [No Abstract]   [Full Text] [Related]  

  • 30. Oral manifestations of psoriasis. Clinical presentation and management.
    Dreyer LN; Brown GC
    N Y State Dent J; 2012 Apr; 78(3):14-8. PubMed ID: 22803270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New contribution to the study of oral psoriasis].
    Brabant H; Ketelbant R
    Rev Stomatol Chir Maxillofac; 1967 Dec; 68(8):613-22. PubMed ID: 5242964
    [No Abstract]   [Full Text] [Related]  

  • 32. Oral Psoriasis: An Overlooked Enigma.
    Fatahzadeh M; Schwartz RA
    Dermatology; 2016; 232(3):319-25. PubMed ID: 27035486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol ointment.
    Sánchez Regaña M; Márquez Balbás G; Umbert Millet P
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):963-9. PubMed ID: 18410337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clobetasol propionate--where, when, why?
    Pels R; Sterry W; Lademann J
    Drugs Today (Barc); 2008 Jul; 44(7):547-57. PubMed ID: 18806904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clobetasol propionate shampoo 0.05%: a new option to treat patients with moderate to severe scalp psoriasis.
    Jarratt M; Breneman D; Gottlieb AB; Poulin Y; Liu Y; Foley V
    J Drugs Dermatol; 2004; 3(4):367-73. PubMed ID: 15303780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alclometasone dipropionate in psoriasis: a clinical study.
    Aggerwal A; Maddin S
    J Int Med Res; 1982; 10(6):414-8. PubMed ID: 7152079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the efficacy and safety of clobetasol propionate spray in the treatment of plaque-type psoriasis.
    Jarratt MT; Clark SD; Savin RC; Swinyer LJ; Safley CF; Brodell RT; Yu K
    Cutis; 2006 Nov; 78(5):348-54. PubMed ID: 17186795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraoral psoriasis vulgaris.
    Rudolph RI; Rudolph LP
    Int J Dermatol; 1975 Mar; 14(2):101-4. PubMed ID: 1091568
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasis.
    Katz HI; Lindholm JS; Weiss JS; Shavin JS; Morman M; Bressinck R; Cornell R; Pariser DM; Pariser RJ; Weng W
    Clin Ther; 1995; 17(3):390-401. PubMed ID: 7585843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psoriasis update.
    Franz R
    Dermatol Nurs; 2001 Jun; 13(3):231-2. PubMed ID: 11917460
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.